PHLI — PacificHealth Laboratories Income Statement
0.000.00%
Last trade - 00:00
Consumer DefensivesHighly SpeculativeMicro Cap
- $0.00m
- -$0.27m
- $6.91m
C2007 December 31st | 2008 December 31st | 2009 December 31st | 2010 December 31st | 2011 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7.43 | 7.24 | 8 | 7.2 | 6.91 |
Cost of Revenue | |||||
Gross Profit | 2.98 | 3.23 | 3.71 | 3.16 | 2.99 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8.79 | 9.28 | 9.94 | 7.96 | 7.39 |
Operating Profit | -1.36 | -2.04 | -1.94 | -0.76 | -0.474 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.28 | -1.99 | -1.94 | -0.761 | -0.486 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.28 | -1.99 | -1.68 | -0.761 | -0.486 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.28 | -1.99 | -1.68 | -0.761 | -0.486 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -1.28 | -1.99 | -1.68 | -0.761 | -0.486 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.063 | -0.097 | -0.087 | -0.047 | -0.025 |
Dividends per Share |